1. Home
  2. BBW vs KLTOW Comparison

BBW vs KLTOW Comparison

Compare BBW & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBW
  • KLTOW
  • Stock Information
  • Founded
  • BBW 1997
  • KLTOW N/A
  • Country
  • BBW United States
  • KLTOW United States
  • Employees
  • BBW N/A
  • KLTOW 3
  • Industry
  • BBW Recreational Games/Products/Toys
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BBW Consumer Discretionary
  • KLTOW Health Care
  • Exchange
  • BBW Nasdaq
  • KLTOW Nasdaq
  • Market Cap
  • BBW 464.1M
  • KLTOW N/A
  • IPO Year
  • BBW 2004
  • KLTOW 2022
  • Fundamental
  • Price
  • BBW $50.28
  • KLTOW $0.25
  • Analyst Decision
  • BBW Strong Buy
  • KLTOW
  • Analyst Count
  • BBW 4
  • KLTOW 0
  • Target Price
  • BBW $54.75
  • KLTOW N/A
  • AVG Volume (30 Days)
  • BBW 235.7K
  • KLTOW N/A
  • Earning Date
  • BBW 08-28-2025
  • KLTOW N/A
  • Dividend Yield
  • BBW 1.77%
  • KLTOW N/A
  • EPS Growth
  • BBW 19.03
  • KLTOW N/A
  • EPS
  • BBW 4.15
  • KLTOW N/A
  • Revenue
  • BBW $510,069,000.00
  • KLTOW N/A
  • Revenue This Year
  • BBW $6.10
  • KLTOW N/A
  • Revenue Next Year
  • BBW $3.90
  • KLTOW N/A
  • P/E Ratio
  • BBW $11.99
  • KLTOW N/A
  • Revenue Growth
  • BBW 6.09
  • KLTOW N/A
  • 52 Week Low
  • BBW $23.63
  • KLTOW N/A
  • 52 Week High
  • BBW $55.57
  • KLTOW N/A
  • Technical
  • Relative Strength Index (RSI)
  • BBW 52.27
  • KLTOW N/A
  • Support Level
  • BBW $50.26
  • KLTOW N/A
  • Resistance Level
  • BBW $54.34
  • KLTOW N/A
  • Average True Range (ATR)
  • BBW 1.75
  • KLTOW 0.00
  • MACD
  • BBW -0.66
  • KLTOW 0.00
  • Stochastic Oscillator
  • BBW 8.01
  • KLTOW 0.00

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: